# Laurence Mignon

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/laurence-mignon/

## Facts

| Field | Value |
| --- | --- |
| Citations | 1,609 |
| Field | Neurotransmitter Receptor Influence on Behavior |
| h-index | 16 |
| i10-index | 18 |
| Last Known Institution | LAM Foundation |
| OpenAlex ID | https://openalex.org/A5085256859 |
| Works | 42 |

## Researcher papers

- [Tau-targeting antisense oligonucleotide MAPTRx in mild Alzheimer’s disease: a phase 1b, randomized, placebo-controlled trial](https://scholariq.org/papers/tau-targeting-antisense-oligonucleotide-maptrx-in-mild-alzheimer-s-disease-a/)
- [Nusinersen in later-onset spinal muscular atrophy](https://scholariq.org/papers/nusinersen-in-later-onset-spinal-muscular-atrophy/)
- [Which comes first: atypical antipsychotic treatment or cardiometabolic risk?](https://scholariq.org/papers/which-comes-first-atypical-antipsychotic-treatment-or-cardiometabolic-risk/)
- [What Was the Set of Ubiquitin and Ubiquitin-Like Conjugating Enzymes in the Eukaryote Common Ancestor?](https://scholariq.org/papers/what-was-the-set-of-ubiquitin-and-ubiquitin-like-conjugating-enzymes-in-the/)
- [Exploratory Tau Biomarker Results From a Multiple Ascending-Dose Study of BIIB080 in Alzheimer Disease](https://scholariq.org/papers/exploratory-tau-biomarker-results-from-a-multiple-ascending-dose-study-of/)
- [Postsynaptic 5-HT1A receptors mediate an increase in locomotor activity in the monoamine-depleted rat](https://scholariq.org/papers/postsynaptic-5-ht1a-receptors-mediate-an-increase-in-locomotor-activity-in-the/)
- [Antisense oligonucleotide targeting DMPK in patients with myotonic dystrophy type 1: a multicentre, randomised, dose-escalation, placebo-controlled, phase 1/2a trial](https://scholariq.org/papers/antisense-oligonucleotide-targeting-dmpk-in-patients-with-myotonic-dystrophy/)
- [Antisense oligonucleotide therapy in an individual with KIF1A-associated neurological disorder](https://scholariq.org/papers/antisense-oligonucleotide-therapy-in-an-individual-with-kif1a-associated/)
- [8-Hydroxy-2-(di-n-propylamino)tetralin reduces striatal glutamate in an animal model of Parkinson??s disease](https://scholariq.org/papers/8-hydroxy-2-di-n-propylamino-tetralin-reduces-striatal-glutamate-in-an-animal/)
- [Postsynaptic 5-HT1A receptor stimulation increases motor activity in the 6-hydroxydopamine-lesioned rat: implications for treating Parkinson’s disease](https://scholariq.org/papers/postsynaptic-5-ht1a-receptor-stimulation-increases-motor-activity-in-the-6/)
- [Assessing the Burden on Caregivers of MECP2 Duplication Syndrome](https://scholariq.org/papers/assessing-the-burden-on-caregivers-of-mecp2-duplication-syndrome/)

## Researcher topics

- [Neurotransmitter Receptor Influence on Behavior](https://scholariq.org/topics/neurotransmitter-receptor-influence-on-behavior/)
- [Alzheimer's disease research and treatments](https://scholariq.org/topics/alzheimer-s-disease-research-and-treatments/)
- [Amyotrophic Lateral Sclerosis Research](https://scholariq.org/topics/amyotrophic-lateral-sclerosis-research/)
- [Genetics and Neurodevelopmental Disorders](https://scholariq.org/topics/genetics-and-neurodevelopmental-disorders/)
- [Parkinson's Disease Mechanisms and Treatments](https://scholariq.org/topics/parkinson-s-disease-mechanisms-and-treatments/)

## Researcher university

- [LAM Foundation](https://scholariq.org/institutions/lam-foundation/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.